Is there a real benefit of hyperbaric oxygenotherapy in the treatment of necrotizing otitis externa?

##plugins.themes.academic_pro.article.sidebar##

Published Sep 22, 2017
Download
pdf
Vol. 94 No. 12 (2016): Issue Dec 2016

##plugins.themes.academic_pro.article.main##

Ali Mardassi
Senda Turki
Rim Lahiani
Hajer Mbarek
Sonia Benzarti
Hédi Gharsallah

Abstract

Introduction: Necrotizing otitis externa remains a severe and sometimes life-threatening disease in diabetic patient. Many therapeutic approaches have been described but what about the real benefit of hyperbaric oxygenotherapy in the management of this disease?

Methods: The authors reported a retrospective study about 42 patients treated for necrotizing external otitis over a period of 9 years (2006 to 2014). The patients were treated either by only antibiotherapy (23 cases) or with both antibiotherapy and hyperbaric oxygenotherapy (19 cases). The evolution under treatment was appreciated in the two groups through clinical, biological and radiological parameters.

Results: The study included 42 diabetic patients with a mean age of 67 years (50 to 84 years). The sex-ratio M/F was 0.82. The diagnosis of necrotizing otitis externa was assessed through clinical and bacteriologic criteria in diabetic patients. A temporal bone CT-scan and a technetium scintigraphy were performed in order to precise the topography of the disease and the level of bone lysis. Antibiotherapy was prescribed intravenously and then orally for a mean period of 8 weeks (5 to 15 weeks). Hyperbaric oxygenotherapy was given for 19 patients (average: 20 sessions). The recovery was affirmed on clinical, biological and radiological features. Otalgia disappeared at the 11th day of treatment without HOT and at the 5th day with HOT. Otorrhea disappeared at the 6th day of treatment by HOT and at the 13th day without HOT. The recovery or the regression of facial palsy occurred in 75% of the cases when HOT was given. The total recovery from the disease was diagnosed in 36 patients (86%). The rate of recovery was 100% in the group treated by HOT and 74% in the group treated by only antibiotics. The recurrence of the disease was noted in 6 patients that haven’t benefited from HOT. The end of the oral therapy was guided by the results of the Gallium bone scintigraphy.

Conclusion: Hyperbaric oxygenotherapy must be associated in the treatment of necrotizing otitis externa. The results of our study suggest a real benefit of this therapy regarding clinical, biological and radiological parameters of this severe affection.

Keywords:

Necrotizing otitis externa, diabetes, antibiotherapy, hyperbaric oxygenotherapy

##plugins.themes.academic_pro.article.details##

References

  1. Hariga I, Mardassi A, Belhaj Younes F, Ben Amor M, Zribi S, Ben Gamra O, Mbarek Ch, El Khedim A. Necrotizing otitis externa: 19 cases' report. Eur Arch Otorhinolaryngol. 2010;267(8):1193-8.
  2. Fang CH, Sun J, Jyung RW. Malignant otitis externa. Ear Nose Throat J. 2015;94:136-8.
  3. Meltzer PE, Kelemen G. Pyocutaneous osteomyelitis of the temporal bone, mandible, and zygoma. Laryngoscope 1959;169:1300-16.
  4. Musa TS, Bemu AN, Grema US, Kirfi AM. Pattern of otitis externa in Kaduna Nigeria. Pan Afr Med J. 2015;21:165.
  5. Hobson CE, Moy JD, Byers KE, Raz Y, Hirsch BE, McCall AA. Malignant Otitis Externa: Evolving Pathogens and Implications for Diagnosis and Treatment. Otolaryngol Head Neck Surg. 2014;151(1):112-6.
  6. Ress BD, Luntz M, Telischi FF, Balkany TJ, Whiteman ML. Necrotizing External Otitis in patients with Aids. Laryngoscope1997;107:465-70.
  7. Somnath S, Kanishka C, Sudipta P, Vedula Padmini S. Malignant otitis externa with bilateral cranial nerve involvement: Report of a unique case. Ind J Otol. 2013; 33-5.
  8. Bovo R, Benatti A, Ciorba A, Libanore M, Borrelli M, Martini A. Pseudomonas and Aspergillus interaction in malignant external otitis: risk of treatment failure. Acta Otorhinolaryngol Ital. 2012;32(6):416-9.
  9. Carifi M, Morandi M, Ruocco T, Napolitano D. Assessing Treatment Efficacy and Progression of Necrotizing Otitis Externa. Otol Neurotol. 2015;36(6):1121.
  10. Heiden C. Malignant otitis externa: experience with hyperbaric oxygen therapy. Diving Hyperb Med. 2010;40(4):182.
  11. Bolton L. Hyperbaric Oxygen Therapy Effects on Chronic Wounds. Wounds. 2015;27(12):354-5.
  12. Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev 2005;2:CD004617.
  13. Narozny W, Kuczkowski J, Stankiewicz C, Kot J and al. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 2006; 263(7):680-4
  14. Duvvi S, Lo S, Kumar R, Blanshard J. Malignant External Otitis With Multiple Cranial Nerve Palsies: The Use Of Hyperbaric Oxygen. Intern J Otorhinolaryngol. 2005.
  15. Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa.Curr Opin Otolaryngol Head Neck Surg 2003;11:316-23.
  16. Singh A, Al Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg 2005;133:121-5.
  17. Narozny W, Kuczkowski J, Stankiewicz C, Kot J, Mikaszewski B, Przewozny T. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 2006;263:680-4.
  18. Berenholz L, Katzenell U, Harell M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope 2002;112:1619-22.
  19. Camporesi EM. Side effects of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41(3):253-7.